Statistics
Publications
330
Citations
89.6K
Authors
24
Location
Omsk, Russia
330
Luis Paz‐Ares, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet · 2019 · 2.2K citations
Medicine, Oncology, Pharmacology +14
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
Robert J. Motzer, B. Yа. Alekseev, Sun Young Rha et al. · New England Journal of Medicine · 2021 · 1.8K citations · Full text
Medicine, Oncology, Pharmacotherapy +12
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma
Toni K. Choueiri, Piotr Tomczak, Se Hoon Park et al. · New England Journal of Medicine · 2021 · 746 citations · Full text
Medicine, Oncology, Pharmacotherapy +13
Jonathan W. Goldman, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet Oncology · 2020 · 687 citations · Full text
Medicine, Oncology, Pharmacology +14
J.F.R. Robertson, Ekaterina Trishkina, Mikhail Dvorkin et al. · The Lancet · 2016 · 602 citations · Full text
Medicine, Oncology, Pharmacology +14
1–5 of 330
24
Budgetary Health Care Institution of the Omsk Region "Clinical Oncology Center", Russia
81 publications · 39K citations
31
h-index
Budgetary Health Care Institution of the Omsk Region "Clinical Oncology Center", Russia
154 publications · 7.1K citations
15
h-index
Budgetary Health Care Institution of the Omsk Region "Clinical Oncology Center", Russia
15 publications · 904 citations
7
h-index
Budgetary Health Care Institution of the Omsk Region "Clinical Oncology Center", Russia
9 publications · 2.9K citations
6
h-index
Budgetary Health Care Institution of the Omsk Region "Clinical Oncology Center", Russia
20 publications · 530 citations
6
h-index
1–5 of 24